CompuMed (OTCMKTS:CMPD) Announces Quarterly Earnings Results

CompuMed (OTCMKTS:CMPDGet Free Report) announced its quarterly earnings results on Monday. The company reported ($0.06) earnings per share for the quarter, Zacks reports. CompuMed had a negative net margin of 0.78% and a negative return on equity of 1.88%.

CompuMed Price Performance

OTCMKTS:CMPD opened at $6.75 on Tuesday. CompuMed has a 52 week low of $1.95 and a 52 week high of $6.95. The company has a quick ratio of 2.01, a current ratio of 2.04 and a debt-to-equity ratio of 0.16. The stock has a market capitalization of $8.98 million, a PE ratio of -134.97 and a beta of -0.53. The stock’s 50-day moving average price is $6.30 and its 200-day moving average price is $4.64.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

See Also

Earnings History for CompuMed (OTCMKTS:CMPD)

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.